“As a result of Lewis solely complained of regulatory, reasonably than fraudulent, violations in his inside communications with AbbVie, the corporate had no cause to assume Lewis’s considerations revolved across the False Claims Act. Extra merely, AbbVie couldn’t have retaliated in opposition to Lewis as a fraud whistleblower as a result of he by no means blew the whistle on fraud, U.S. Courtroom of Appeals for the Seventh Circuit Choose Joshua P. Kolar mentioned.
Trending
- Thousands of drivers wrongly fined for speeding since 2021
- Landmark agreement means Disney characters are coming to OpenAI Sora
- Row deepens as three board members removed
- Top 5 Branded Videos of the Week: YouTube Recap pepperoni
- UK launches taskforce to ‘break down barriers’ for women in tech
- Ford takes $19.5bn hit amid electric vehicle retreat as Trump policies bite | Ford
- Albertsons’ New Ad Format Tries to Solve a Major Challenge in Retail Media
- The giant heat pumps designed to warm whole districts

